RE:RE:RE:RE:Ooodles of CASH for now, but waaay more Beech-bull ; - )Thx AP
So we could have as much as $ 17M + warrant/option exercising, less cash burn for Q4 and Q1 ...with no real liabilities to worry about.
Can't imagine that the burn/Trial costs were that significant during those months that we were only enrolling 1 or 2 patients (H2 2021). To be fair, there is the big salaries & perks and all (for a job well done)
Maybe a spin-off or new partner on Dialco will inject some more cash? That would sure put a feather in Seto's cap...and explain why the BoD like him so much.
If the Tigris Trial really is back on track and "exceeding expectations" I can imagine that that is some news that a Where's Walden (once found) would love to share with some would be US investors!